• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甾体类药物分析。第40部分。双醋炔诺醇中异常杂质的分离与鉴定]

[Analysis of steroids. Part 40. Isolation and identification of unusual impurities in ethynodiol diacetate].

作者信息

Görög S, Halmos Z, Herényi B, Georgakis A, Balogh G, Csizér E, Tuba Z

机构信息

Richter Gedeon Vegyészeti Gyár Rt., Budapest.

出版信息

Acta Pharm Hung. 1991 Mar;61(2):77-81.

PMID:1887802
Abstract

In the course of the estimation of the impurity profile of ethynodiol diacetate, in addition to common impurities such as norethisterone acetate, ethynodiol-3-acetate and alpha-ethynodiol diacetate, two unknown impurities were detected by analytical reversed phase HPLC (C-18 silica and 80% aq. methanol as the eluent) and isolated by normal phase preparative HPLC (silica and 98:2 mixture of hexane and 2-propanol as the eluent). The 1H- and 13C-NMR spectra of the isolated impurities revealed that their structures could be characterized as the E and Z isomers of an analogue of EDDA containing "trimerised acetyl" group at the 17-hydroxy group (structures 4 and 4a). These structures were in good agreement with the extended UV spectra of the impurities and the mass spectra with the m/z 438 peak which can be derived from 4 and 4a by the loss of ketene.

摘要

在对炔诺酮双醋酸酯杂质概况的评估过程中,除了常见杂质如醋酸炔诺酮、3 - 醋酸炔诺醇和α - 炔诺酮双醋酸酯外,通过反相分析型高效液相色谱法(C - 18硅胶,80% 甲醇水溶液作为洗脱剂)检测到两种未知杂质,并通过正相制备型高效液相色谱法(硅胶,己烷与2 - 丙醇98:2混合物作为洗脱剂)进行分离。分离出的杂质的1H - 和13C - NMR光谱显示,它们的结构可表征为在17 - 羟基处含有“三聚乙酰基”基团的炔诺酮双醋酸酯类似物的E型和Z型异构体(结构4和4a)。这些结构与杂质的扩展紫外光谱以及具有m/z 438峰的质谱图非常吻合,该峰可由4和4a失去乙烯酮得到。

相似文献

1
[Analysis of steroids. Part 40. Isolation and identification of unusual impurities in ethynodiol diacetate].[甾体类药物分析。第40部分。双醋炔诺醇中异常杂质的分离与鉴定]
Acta Pharm Hung. 1991 Mar;61(2):77-81.
2
Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
J Pharm Biomed Anal. 2002 Aug 1;29(6):1153-7. doi: 10.1016/s0731-7085(02)00165-6.
3
[Analysis of steroids. Part 42. By-products of the ethynylation of 17-ketosteroids (isolation, identification and determination)].[甾体类化合物分析。第42部分。17-酮甾体乙炔化的副产物(分离、鉴定与测定)]
Acta Pharm Hung. 1991 Mar;61(2):98-104.
4
Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.盐酸克林霉素棕榈酸酯杂质的鉴别、分离与表征
J Pharm Biomed Anal. 2008 Dec 1;48(4):1211-8. doi: 10.1016/j.jpba.2008.08.011. Epub 2008 Aug 20.
5
Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.富马酸喹硫平杂质的鉴定、分离、合成与表征
Pharmazie. 2008 Jan;63(1):14-9.
6
Isolation and characterization of some potential impurities in ropinirole hydrochloride.盐酸罗匹尼罗中某些潜在杂质的分离与表征
J Pharm Biomed Anal. 2007 Mar 12;43(4):1587-93. doi: 10.1016/j.jpba.2006.11.030. Epub 2007 Jan 4.
7
Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.COX-2抑制剂塞来昔布中杂质的分离、合成与表征
J Pharm Biomed Anal. 2004 Jun 29;35(4):951-7. doi: 10.1016/j.jpba.2004.02.037.
8
Isolation and structural identification of an impurity in fluconazole bulk drug substance.氟康唑原料药中一种杂质的分离与结构鉴定
J Pharm Biomed Anal. 2007 Nov 5;45(3):422-9. doi: 10.1016/j.jpba.2007.06.029. Epub 2007 Jul 10.
9
Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.用反相高效液相色谱法/电喷雾电离质谱法分离和鉴定三氯苯达唑的合成杂质
J Pharm Biomed Anal. 2005 Feb 7;37(1):97-107. doi: 10.1016/j.jpba.2004.09.049.
10
Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.采用质谱位移技术的高效液相色谱-质谱联用仪对半合成酒石酸长春瑞滨中的杂质进行表征。
J Pharm Biomed Anal. 2005 Sep 1;39(1-2):39-45. doi: 10.1016/j.jpba.2005.02.042.